Product portfolio
At Novartis, we reimagine medicine to improve and extend people’s lives. This includes discovering and developing breakthrough therapies and finding new ways to deliver these treatments to as many people as possible.
Products are listed alphabetically by brand name. This is not complete medical or product information. Click on the highlighted links next to the product names for complete prescribing information, including important safety information.
If you have a medical condition, promptly see your physician or other healthcare provider.
Showing 70 results
-
Desferal® (deferoxamine mesylate for injection, USP)
(vials)Resources -
Cosentyx® (secukinumab)
(injection, for subcutaneous use) -
Coartem® (artemether/ lumefantrine)
(tablets) -
Betoptic S® (betaxolol hydrochloride ophthalmic suspension) 0.25%
(sterile topical ophthalmic drops) -
Beovu® (brolucizumab-dbll)
(injection, for intravitreal use) -
Arzerra® (ofatumumab)
(injection, for intravenous use) -
Aimovig® (erenumab-aooe)
(injection, for subcutaneous use) -
Afinitor® (everolimus) tablets for oral administration
(tablets for oral administration)Resources -
Afinitor® Disperz (everolimus tablets for oral suspension)
(tablets for oral suspension) -
Adakveo® (crizanlizumab-tmca)
(injection, for intravenous use)
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- › Next page